78 related articles for article (PubMed ID: 17384177)
1. MHC class II expression on myeloid cells inversely correlates with disease progression in early rheumatoid arthritis.
Mueller RB; Skapenko A; Wendler J; Schuch F; Kalden JR; Schulze-Koops H
Rheumatology (Oxford); 2007 Jun; 46(6):931-3. PubMed ID: 17384177
[TBL] [Abstract][Full Text] [Related]
2. Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor.
Mueller RB; Skapenko A; Grunke M; Wendler J; Stuhlmuller B; Kalden JR; Schulze-Koops H
Arthritis Rheum; 2005 Feb; 52(2):451-60. PubMed ID: 15692975
[TBL] [Abstract][Full Text] [Related]
3. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment.
Wijngaarden S; van Roon JA; van de Winkel JG; Bijlsma JW; Lafeber FP
Rheumatology (Oxford); 2005 Jun; 44(6):729-34. PubMed ID: 15757966
[TBL] [Abstract][Full Text] [Related]
5. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
[TBL] [Abstract][Full Text] [Related]
6. Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis.
Cross A; Bucknall RC; Cassatella MA; Edwards SW; Moots RJ
Arthritis Rheum; 2003 Oct; 48(10):2796-806. PubMed ID: 14558085
[TBL] [Abstract][Full Text] [Related]
7. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
[TBL] [Abstract][Full Text] [Related]
8. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
[TBL] [Abstract][Full Text] [Related]
9. Relationship between serum hyaluronic acid level and disease activity in early rheumatoid arthritis.
Majeed M; McQueen F; Yeoman S; McLean L
Ann Rheum Dis; 2004 Sep; 63(9):1166-8. PubMed ID: 15308530
[TBL] [Abstract][Full Text] [Related]
10. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
Tsujimura S; Saito K; Nawata M; Nakayamada S; Tanaka Y
Ann Rheum Dis; 2008 Mar; 67(3):380-8. PubMed ID: 17660216
[TBL] [Abstract][Full Text] [Related]
11. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab.
Sekiguchi N; Kawauchi S; Furuya T; Inaba N; Matsuda K; Ando S; Ogasawara M; Aburatani H; Kameda H; Amano K; Abe T; Ito S; Takeuchi T
Rheumatology (Oxford); 2008 Jun; 47(6):780-8. PubMed ID: 18388148
[TBL] [Abstract][Full Text] [Related]
12. Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.
van Tuyl LH; Lems WF; Voskuyl AE; Kerstens PJ; Garnero P; Dijkmans BA; Boers M
Ann Rheum Dis; 2008 Nov; 67(11):1574-7. PubMed ID: 18625629
[TBL] [Abstract][Full Text] [Related]
13. Regulation of CXCL16 expression and secretion by myeloid cells is not altered in rheumatoid arthritis.
van Lieshout AW; van der Voort R; Toonen LW; van Helden SF; Figdor CG; van Riel PL; Radstake TR; Adema GJ
Ann Rheum Dis; 2009 Jun; 68(6):1036-43. PubMed ID: 18628285
[TBL] [Abstract][Full Text] [Related]
14. Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis.
Kuriya B; Cheng CK; Chen HM; Bykerk VP
Ann Rheum Dis; 2009 Sep; 68(9):1482-5. PubMed ID: 19015211
[TBL] [Abstract][Full Text] [Related]
15. Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activity.
Vander Cruyssen B; Miltenburg AM; Van den Bosch F; Houbiers JG; Wittoek R; Boots AM; De Keyser F
J Rheumatol; 2007 Oct; 34(10):1992-6. PubMed ID: 17924607
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
Martins I; Sylla K; Deshayes F; Lauriol J; Ghislin S; Dieu-Nosjean MC; Viguier M; Verola O; Charron D; Alcaide-Loridan C; Al-Daccak R
Melanoma Res; 2009 Aug; 19(4):226-37. PubMed ID: 19574933
[TBL] [Abstract][Full Text] [Related]
17. The development of rheumatoid arthritis after recombinant hepatitis B vaccination.
Pope JE; Stevens A; Howson W; Bell DA
J Rheumatol; 1998 Sep; 25(9):1687-93. PubMed ID: 9733447
[TBL] [Abstract][Full Text] [Related]
18. The severity of rheumatoid arthritis: a 6-year followup study of younger women with symptoms of recent onset.
van Zeben D; Hazes JM; Zwinderman AH; Vandenbroucke JP; Breedveld FC
J Rheumatol; 1994 Sep; 21(9):1620-5. PubMed ID: 7799338
[TBL] [Abstract][Full Text] [Related]
19. Plasma level of CXC-chemokine CXCL12 is increased in rheumatoid arthritis and is independent of disease activity and methotrexate treatment.
Hansen IB; Ellingsen T; Hornung N; Poulsen JH; Lottenburger T; Stengaard-Pedersen K
J Rheumatol; 2006 Sep; 33(9):1754-9. PubMed ID: 16960937
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma expression in monocytes/macrophages from rheumatoid arthritis patients: relation to disease activity and therapy efficacy--a pilot study.
Palma A; Sainaghi PP; Amoruso A; Fresu LG; Avanzi G; Pirisi M; Brunelleschi S
Rheumatology (Oxford); 2012 Nov; 51(11):1942-52. PubMed ID: 22829690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
